519 related articles for article (PubMed ID: 9285792)
1. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
[TBL] [Abstract][Full Text] [Related]
2. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.
Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R
Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747
[TBL] [Abstract][Full Text] [Related]
3. Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.
Sperandeo MP; Ungaro P; Vernucci M; Pedone PV; Cerrato F; Perone L; Casola S; Cubellis MV; Bruni CB; Andria G; Sebastio G; Riccio A
Am J Hum Genet; 2000 Mar; 66(3):841-7. PubMed ID: 10712200
[TBL] [Abstract][Full Text] [Related]
4. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway.
Brown KW; Villar AJ; Bickmore W; Clayton-Smith J; Catchpoole D; Maher ER; Reik W
Hum Mol Genet; 1996 Dec; 5(12):2027-32. PubMed ID: 8968759
[TBL] [Abstract][Full Text] [Related]
5. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome.
Engel JR; Smallwood A; Harper A; Higgins MJ; Oshimura M; Reik W; Schofield PN; Maher ER
J Med Genet; 2000 Dec; 37(12):921-6. PubMed ID: 11106355
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome.
Catchpoole D; Lam WW; Valler D; Temple IK; Joyce JA; Reik W; Schofield PN; Maher ER
J Med Genet; 1997 May; 34(5):353-9. PubMed ID: 9152830
[TBL] [Abstract][Full Text] [Related]
7. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain.
Reik W; Brown KW; Schneid H; Le Bouc Y; Bickmore W; Maher ER
Hum Mol Genet; 1995 Dec; 4(12):2379-85. PubMed ID: 8634713
[TBL] [Abstract][Full Text] [Related]
8. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
Sparago A; Cerrato F; Vernucci M; Ferrero GB; Silengo MC; Riccio A
Nat Genet; 2004 Sep; 36(9):958-60. PubMed ID: 15314640
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
Wada M; Seeger RC; Mizoguchi H; Koeffler HP
Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
[TBL] [Abstract][Full Text] [Related]
10. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
Reeve AE
Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
[TBL] [Abstract][Full Text] [Related]
11. A novel IGF2/H19 domain triplication in the 11p15.5 imprinting region causing either Beckwith-Wiedemann or Silver-Russell syndrome in a single family.
Jurkiewicz D; Kugaudo M; Skórka A; Śmigiel R; Smyk M; Ciara E; Chrzanowska K; Krajewska-Walasek M
Am J Med Genet A; 2017 Jan; 173(1):72-78. PubMed ID: 27612309
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive high-resolution melting.
Wojdacz TK; Dobrovic A; Algar EM
Hum Mutat; 2008 Oct; 29(10):1255-60. PubMed ID: 18473334
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.
Cerrato F; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Rinaldi MM; Boccuto L; Neri G; Magnani C; D'Angelo P; Collini P; Perotti D; Sebastio G; Maher ER; Riccio A
Hum Mol Genet; 2008 May; 17(10):1427-35. PubMed ID: 18245780
[TBL] [Abstract][Full Text] [Related]
14. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
15. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
[TBL] [Abstract][Full Text] [Related]
16. Somatic overgrowth associated with overexpression of insulin-like growth factor II.
Morison IM; Becroft DM; Taniguchi T; Woods CG; Reeve AE
Nat Med; 1996 Mar; 2(3):311-6. PubMed ID: 8612230
[TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting mutations define both distinct and overlapping roles for misexpression of IGF2 and of H19 lncRNA.
Park KS; Mitra A; Rahat B; Kim K; Pfeifer K
Nucleic Acids Res; 2017 Dec; 45(22):12766-12779. PubMed ID: 29244185
[TBL] [Abstract][Full Text] [Related]
18. Genomic imprinting of IGF2 and H19 in human meningiomas.
Müller S; Zirkel D; Westphal M; Zumkeller W
Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131
[TBL] [Abstract][Full Text] [Related]
19. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
[TBL] [Abstract][Full Text] [Related]
20. A novel de novo point mutation of the OCT-binding site in the IGF2/H19-imprinting control region in a Beckwith-Wiedemann syndrome patient.
Higashimoto K; Jozaki K; Kosho T; Matsubara K; Fuke T; Yamada D; Yatsuki H; Maeda T; Ohtsuka Y; Nishioka K; Joh K; Koseki H; Ogata T; Soejima H
Clin Genet; 2014 Dec; 86(6):539-44. PubMed ID: 24299031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
